1. AstraZeneca, Lilly, Sanofi, and others raise prices to start July — Merck gets a CRL from FDA on Keytruda for hepatocellular carcinoma — 2020 biotech IPOs continue to break records — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

First Otonomy Thread

Discussion in 'Otonomy' started by anonymous, Feb 26, 2016 at 4:19 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Let the games begin!!!!!!
     

  2. anonymous

    anonymous Guest

    no one wants a long acting high price ear antibiotic to increase the kit price
    Patients, physicians, payers (cms) and hospitals won't. You can't even play in the game
     
  3. anonymous

    anonymous Guest

    What a stupid name for a company! Just terrible!
     
  4. anonymous

    anonymous Guest

    So how are Otonmy sales going? Was thinking it would be a huge challenge to try and sell ear drops that were significantly higher in price versus what they already use simply because it will adhere to the ear longer. How has ENT been in terms of getting it on formulary?
     
  5. anonymous

    anonymous Guest

    Could not agree more. Imagine....they paid money for someone to come up with this name too.
     
  6. anonymous

    anonymous Guest

    Turned down a job offer with this company. During the interview process, I could never get a straight response to the question "what is the value proposition offered vs. existing treatment options?" Give me tolerability, compliance, SOMETHING. Serious red flag raised and I walked. Seemed like nice people however, so I wish them success.
     
  7. anonymous

    anonymous Guest

     
  8. anonymous

    anonymous Guest

    might be the last. get out there and sell sell sell
     
  9. anonymous

    anonymous Guest


    Any pussy over there? I'm considering a territory.
     
  10. anonymous

    anonymous Guest

    If there is such a thing as a Tier 198,382 in PBMs, this will have it.

    395% copay, just to penalize the patient for allowing their doc to write it.

    Ketek all over again.
     
  11. anonymous

    anonymous Guest


    Joke of a company. So glad they passed me over!
     
  12. anonymous

    anonymous Guest

    Let me help you troll a little better, since you are obviously so uninformed. This drug *which cannot be named due to compliance reasons* is not even available to fail via PBM. P = Pharmacy. We will fail exclusively through the medical benefit. You're welcome.
     
  13. anonymous

    anonymous Guest

    LOL!! You mean Otiprio? What is this Harry Potter? He who must not be named.... Are you 12?
     
  14. anonymous

    anonymous Guest

    Consider yourself lucky!
     
  15. anonymous

    anonymous Guest

    Price is 3x too high and everyone knows it.
     
  16. anonymous

    anonymous Guest

    Wow!!!
     
  17. anonymous

    anonymous Guest

    Boy are you stupid. It's clear the original poster was referring sarcastically to the compliance department not allowing us to say Otiprio. No wonder this company is failing. I bet you were involved in planning the launch. Great job.
     
  18. Bmac123

    Bmac123 Guest

    The only reason to own this company is OTO-104 - the value prop is simple - there is NO cure for Meniere's. Steroids only works for a few days because they cant stay in the inner ear.
    This steroid (gel) is designed to be in the ear for several months. It will change the lives of Meniere's patients all over the world. (forget about the swimmers ear drug - useless - just a warm up for the big guy OTO-104)

    I was diagnosed with Meniere's disease almost 10 years ago. I wish them all the luck world.
    If this drug hits...trust me you will want to be along for the ride. Millions of patients will be lining up at ENT's all over the world.
     
  19. anonymous

    anonymous Guest

    It's nice to be reminded about what matters. Thanks for bringing some positivity to this toxic board. Thankfully there are a lot of us dedicated to help, rather than complaining... jobs gotta get done and the movers and shakers will leave the naysayers in the dust.
     
  20. anonymous

    anonymous Guest

    This says it all